Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant

被引：10
|
作者：
Carlini, A [1 ]
Angelini, D
Burrows, L
De Quirico, G
Antonelli, A
机构：
[1] Campo Marte Hosp, Dept Nephrol, I-55100 Lucca, Italy
[2] Campo Marte Hosp, Dept Radiol, I-55100 Lucca, Italy
[3] Mt Sinai Hosp, Dept Renal Transplantat, New York, NY 10029 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 10期
关键词：
cerebral aspergillosis; liposomal amphotericin B; nefrotoxicity; renal transplant;
D O I：
10.1093/ndt/13.10.2659
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：2659 / 2661
页数：3
相关论文
共 50 条
  • [21] Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis
    Gavaldà, J
    Martín, T
    López, P
    Gomis, X
    Ramírez, JL
    Rodríguez, D
    Len, O
    Puigfel, Y
    Ruiz, I
    Pahissa, A
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (12) : 999 - 1004
  • [22] Amphotericin-B liposomal/corticosteroids/nivolumabInvasive pulmonary aspergillosis and lack of efficacy: case report
    Reactions Weekly, 2022, 1904 (1) : 36 - 36
  • [23] PROPHYLACTIC EFFICACY OF AEROSOLIZED LIPOSOMAL (AMBISOME) AND NON-LIPOSOMAL (FUNGIZONE) AMPHOTERICIN-B IN MURINE PULMONARY ASPERGILLOSIS
    ALLEN, SD
    SORENSEN, KN
    NEJDL, MJ
    DURRANT, C
    PROFFIT, RT
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (06) : 1001 - 1013
  • [24] Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS
    Johnson, PC
    Wheat, LJ
    Cloud, GA
    Goldman, M
    Lancaster, D
    Bamberger, DM
    Powderly, WG
    Hafner, R
    Kauffman, CA
    Dismukes, WE
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (02) : 105 - 109
  • [25] Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis
    Newton, Pippa J.
    Harris, Chris
    Morris, Julie
    Denning, David W.
    JOURNAL OF INFECTION, 2016, 73 (05) : 485 - 495
  • [26] Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis
    Elanjikal, Z
    Sörensen, J
    Schmidt, H
    Dupuis, W
    Tintelnot, K
    Jautzke, G
    Klingebiel, T
    Lehrnbecher, T
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (07) : 653 - 656
  • [27] Aspergillosis: Nebulized liposomal amphotericin-B for maintenance therapy?
    Simon, Annika
    PNEUMOLOGIE, 2023, 77 (01): : 8 - 8
  • [28] Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children
    Sunakawa, Keisuke
    Tsukimoto, Ichiro
    Tsunematsu, Yukiko
    Honda, Masatada
    Iwai, Naoichi
    Maniwa, Takashi
    Haigo, Hisamatsu
    Suzuki, Kota
    Mori, Takeshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (04) : 456 - 465
  • [29] High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient
    Brazzola, Pierluigi
    Rossi, Mario R.
    MEDICAL MYCOLOGY CASE REPORTS, 2014, 3 : 1 - 3
  • [30] Is liposomal amphotericin B really safety in neonates?
    Karadag-Oncel, Eda
    Ozsurekci, Yasemin
    Yurdakok, Murat
    Kara, Ates
    EARLY HUMAN DEVELOPMENT, 2013, 89 (01) : 35 - 36
12345